NEO
USDNeoGenomics Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$10.200
Kõrge
$10.317
Madal
$9.780
Maht
2.66M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
1.3B
Tööstusharu
Diagnostics & Research
Riik
United States
Kauplemisstatistika
Keskmine maht
3.47M
Börs
NCM
Valuuta
USD
52 nädala vahemik
Seotud uudised
NeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
Additional presentations to focus on liquid biopsy– MRD based detection and genomic profiling across solid tumors NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable
NeoGenomics Reports Third Quarter 2025 Results
Third quarter total revenue increased 12% YoY to $188 million Clinical revenue grew 18%, or 15% excluding the Pathline acquisition NGS revenue increased 24% YoY and now accounts for nearly one-third of clinical
NeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today announced the presentation of assay-relevant data, including interventional therapy trials in
Seotud aktsiad
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.